CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ADMA — Adma Biologics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ADMA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,882,905
-$22,297,688 QoQ
Shares Held
2,095,772
-7.2% QoQ
Ownership
0.904%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99.98873923308452.ToString("F0")%
Shared 0.ToString("F0")%
None 0.01126076691548508.ToString("F0")%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,181,979,796 across 287 Biotechnology names. ADMA ranks #63 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in ADMA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,882,905 | 2,095,772 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $41,180,593 | 2,257,708 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $34,608,814 | 2,360,765 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $45,561,893 | 2,502,026 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $48,846,179 | 2,462,005 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $41,851,042 | 2,440,294 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $48,006,644 | 2,401,533 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $24,060,712 | 2,152,121 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $11,715,792 | 1,775,120 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,397,897 | 1,636,703 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,761,458 | 1,609,346 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,101,281 | 569,453 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,860,954 | 562,222 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,885,718 | 486,010 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,162,055 | 478,212 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $945,594 | 477,573 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $126,685 | 69,227 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $97,610 | 69,227 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $94,283 | 58,927 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $311,967 | 177,254 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $306,163 | 157,007 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $346,382 | 144,930 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $450,127 | 153,627 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $498,971 | 173,254 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||